SCHEMBL19082290

SCHEMBL19082290

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5cc7c(cc56)sc5ccc6ccccc6c57)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
F9 P00740 3/20 0.34
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
ALOX5 P09917 2/20 0.32
S1PR4 O95977 2/20 0.32
S1PR5 Q9H228 2/20 0.32
MCL1 Q07820 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B1 P14061 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082286 0.96 ESR1 (0.35) ESR1ESR2F9NQO2NQO1
SCHEMBL19082196 0.95 F9 (0.39) ESR1ESR2F9NQO2NQO1
SCHEMBL19082341 0.95 F9 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL17943979 0.94 ESR1 (0.38) ESR1ESR2F9NQO2NQO1
SCHEMBL19082131 0.92 NQO2 (0.35) ESR1ESR2F9NQO2NQO1
SCHEMBL19082148 0.92 CYP1A1 (0.35) ESR1ESR2F9NQO2NQO1
SCHEMBL19082343 0.91 F9 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082201 0.91 F9 (0.39) ESR1ESR2F9NQO2NQO1
SCHEMBL19082092 0.91 CYP1A1 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082171 0.90 HSD17B1 (0.35) ESR1ESR2F9NQO2NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.